MedPath

唐山隆康药业有限公司

Ownership
-
Established
2004-04-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H13021376
Approval Date
Oct 12, 2020
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H13021384
Approval Date
Oct 12, 2020
NMPA

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H13021387
Approval Date
Oct 12, 2020
NMPA

Compound Diclofenac Sodium and Chlorphenamine Maleate Tablets

Product Name
氯芬黄敏片
Approval Number
国药准字H13023759
Approval Date
Oct 12, 2020
NMPA

Pipemidic Acid Tablets

Product Name
吡哌酸片
Approval Number
国药准字H13021388
Approval Date
Oct 12, 2020
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H13021383
Approval Date
Oct 12, 2020
NMPA

Diclofenac Sodium Enteric-coated Tablets

Product Name
双氯芬酸钠肠溶片
Approval Number
国药准字H13024097
Approval Date
Oct 12, 2020
NMPA

Dipyridamole Tablets

Product Name
双嘧达莫片
Approval Number
国药准字H13021380
Approval Date
Oct 12, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H13021382
Approval Date
Oct 12, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H13021381
Approval Date
Oct 12, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.